A generation that thinks and feels differently Gen Z is the first generation to enter medicine as digital natives, but their ...

Lilly has announced plans to build a $6bn facility in Alabama in the US for the manufacture of active pharmaceutical ...

Kymera Therapeutics has announced positive results from its trial of KT-621 to treat patients with moderate to severe atopic ...

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and ...

The US FDA has announced the launch of the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices ...

Our Nature Custom Media team recently took on an ambitious project: producing a video that spanned two continents, covered a ...

Eli Lilly has appointed Carolyn Bertozzi to its Board of Directors as a returning member, after she served on Lilly’s board ...

Novo Nordisk has presented new findings from its phase 3 Evoke and Evoke+ trials on using semaglutide as part of Alzheimer’s ...

At ISPOR Europe in Glasgow, there were literal queues around the block for Tim Wright's HEOR Theater presentation 'MFN Pricing: More Fun to Navigate – A European Roadmap to Success,' with potentially ...

Today’s audiences listen simultaneously to multiple channels, from social media to digital detailing, which leak into each other like a commuter’s headphones on a crowded train ...

Exhibitions remain one of the most powerful ways for pharmaceutical and life sciences organisations to connect, educate and ...

The US, EU and UK operate under different systems, with distinct expectations for clinical evidence, timelines and commercial ...